Abstract:Lipotoxicity plays a vital role in development and progression of type 2 diabetes. Prolonged elevation of free fatty acids especially the palmitate leads to pancreatic β-cell dysfunction and apoptosis. Curcumin (diferuloylmethane), a polyphenol from the curry spice turmeric, is considered to be a broadly cytoprotective agent. The present study was designed to determine the protective effect of curcumin on palmitate-induced apoptosis in β-cells and investigate underlying mechanisms. Our results showed that curc… Show more
“…Importantly, a recent clinical trial demonstrated that curcumin intervention in pre-diabetic human subjects lowered the number of individuals who eventually progressed to T2D [18] . Numerous in vitro investigations [17,[20][21][22][23][24][25][26] . For example, Pan et al investigated the protective effects of the curcumin derivative C66 on diabetic cardiomyopathy.…”
Section: Dietary Polyphenol and Dietary Polyphenol Interventionmentioning
confidence: 99%
“…We found that this shortterm curcumin treatment effectively ameliorated muscular oxidative stress by activation of the anti-oxidative Nrf2 signaling cascade [27] . A recent study by Hao et al demonstrated that in the mouse pancreatic MIN6 β-cell line, curcumin attenuated palmitate-induced cell death, possibly via the activation of cell survival Akt signaling and the inhibition of nuclear translocation of FoxO1 [26] .…”
Section: Dietary Polyphenol and Dietary Polyphenol Interventionmentioning
Numerous natural products available over the counter are commonly consumed by healthy, sub-healthy or ill people for the treatment and prevention of various chronic diseases. Among them, a few dietary polyphenols, including the curry compound curcumin, have been attracting the most attention from biomedical researchers and drug developers. Unlike many so-called "good drug candidates", curcumin and several other dietary polyphenols do not have a single known therapeutic target or defined receptor. In addition, the bioavailability of these polyphenols is usually very low due to their poor absorption in the gut. These recently debated features have created enormous difficulties for drug developers. In this review, I do not discuss how to develop curcumin, other dietary polyphenols or their derivatives into pharmaceutical agents. Instead, I comment on how curcumin and dietary polyphenol research has enriched our knowledge of insulin signaling, including the presentation of my perspectives on how these studies will add to our understanding of the famous hepatic insulin function paradox.
“…Importantly, a recent clinical trial demonstrated that curcumin intervention in pre-diabetic human subjects lowered the number of individuals who eventually progressed to T2D [18] . Numerous in vitro investigations [17,[20][21][22][23][24][25][26] . For example, Pan et al investigated the protective effects of the curcumin derivative C66 on diabetic cardiomyopathy.…”
Section: Dietary Polyphenol and Dietary Polyphenol Interventionmentioning
confidence: 99%
“…We found that this shortterm curcumin treatment effectively ameliorated muscular oxidative stress by activation of the anti-oxidative Nrf2 signaling cascade [27] . A recent study by Hao et al demonstrated that in the mouse pancreatic MIN6 β-cell line, curcumin attenuated palmitate-induced cell death, possibly via the activation of cell survival Akt signaling and the inhibition of nuclear translocation of FoxO1 [26] .…”
Section: Dietary Polyphenol and Dietary Polyphenol Interventionmentioning
Numerous natural products available over the counter are commonly consumed by healthy, sub-healthy or ill people for the treatment and prevention of various chronic diseases. Among them, a few dietary polyphenols, including the curry compound curcumin, have been attracting the most attention from biomedical researchers and drug developers. Unlike many so-called "good drug candidates", curcumin and several other dietary polyphenols do not have a single known therapeutic target or defined receptor. In addition, the bioavailability of these polyphenols is usually very low due to their poor absorption in the gut. These recently debated features have created enormous difficulties for drug developers. In this review, I do not discuss how to develop curcumin, other dietary polyphenols or their derivatives into pharmaceutical agents. Instead, I comment on how curcumin and dietary polyphenol research has enriched our knowledge of insulin signaling, including the presentation of my perspectives on how these studies will add to our understanding of the famous hepatic insulin function paradox.
“…Bcl-2 is one of antiapoptotic Bcl-2 family proteins, which regulates the mitochondrial pathway [33]. Several studies showed that curcumin can block the oxidative stress mediated apoptosis via suppressing the mitochondria apoptotic pathway against cisplatin, palmitate and 6-hydroxydopamin induced cytotoxicity [47][48][49]. These data indicated that curcumin protected L02 cells against FZD induced apoptosis via inhibiting mitochondrial pathway.…”
Furazolidone (FZD), a synthetic nitrofuran derivative, has been widely used as an antibacterial and antiprotozoal agent. Recently, the potential toxicity of FZD has raised concerns, but its mechanism is still unclear. This study aimed to investigate the protective effect of curcumin on FZD induced cytotoxicity and the underlying mechanism in human hepatocyte L02 cells. The results showed that curcumin pre-treatment significantly ameliorated FZD induced oxidative stress, characterized by decreased reactive oxygen species (ROS) and malondialdehyde formations, and increased superoxide dismutase, catalase activities and glutathione contents. In addition, curcumin pre-treatment significantly ameliorated the loss of mitochondrial membrane potential, the activation of caspase-9 and -3, and apoptosis caused by FZD. Alkaline comet assay showed that curcumin markedly reduced FZD-induced DNA damage in a dose-dependent manner. Consistently, curcumin pre-treatment markedly down-regulated the mRNA expression levels of p53, Bax, caspase-9 and -3 and up-regulated the mRNA expression level of Bcl-2. Taken together, these results revealed that curcumin protects against FZD induced DNA damage and apoptosis via inhibiting oxidative stress and mitochondrial pathway. Our study indicated that curcumin may be a promising combiner with FZD to reduce FZD-related toxicity in the clinical applications.
“…In lung cancer, curcumin induces apoptosis accompanied by changes in intracellular oxidative stress-related enzymes and also by phosphorylation and activation of the mitogen-activated protein kinase signaling pathway factors c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase (Yao et al 2015). In pancreatic B cells, curcumin attenuates palmitate-induced apoptosis through PI3K/AKT/Fox01 and mitochondrial survival pathways (Hao et al 2015). A decrease in ROS with a concomitant increase in various antioxidant and DNA repair genes, such as BRCA-1, H2AFX, and PARP-1, were observed after curcumin treatment (Jain et al 2015).…”
Cancer is a leading cause of death worldwide, and treating advanced stages of cancer remains clinically challenging. Epidemiological studies have shown that oxidants and free radicals induced DNA damage is one of the predominant causative factors for cancer pathogenesis. Hence, oxidants are attractive targets for chemoprevention as well as therapy. Dietary agents are known to exert an anti-oxidant property which is one of the most efficient preventive strategy in cancer progression. In this article, we highlight dietary agents can potentially target oxidative stress, in turn delaying, preventing, or treating cancer development. Some of these agents are currently in use in basic research, while some have been launched successfully into clinical trials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.